The inhibition of lidocaine metabolism by various barbiturates in rat hepatic microsome

Japanese Journal of Anesthesiology

Volumn 47, Issue 11, 1998, Pages 1309-1310

  Kakinohana, Manabu ^a   Taira, Yutaka ^a   Kakinohana, Osamu ^a   Okuda, Yoshiaki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; LIDOCAINE; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; DRUG METABOLISM; DRUG PROTEIN BINDING; LIVER MICROSOME; LOCAL ANESTHESIA; NONHUMAN; RAT;

ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BARBITURATES; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; LIDOCAINE; MALE; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; RATS; RATS, WISTAR;

EID: 0031758868     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Heel RC, Avery G S : Cardiac arrythmias, Drug Traetment. Edited by Avery GS. Australia, ADIS Press, 1980, p 586
2. Chen-Yu S, Truant AP: The physiological disposition of lidocaine and its comparison in some respects with procaine. Pharmacol Exp Ther 112: 432, 1954
3. Hollunger G : On the metabolism of lidocaine II. The biotransformation of lidocaine. Acta Pharmacol et Toxicol 17: 365, 1960
4. Difazio CA, Brown RE : Lidocaine metabolism in normal and phénobarbital pretreated dogs. Anesthesiology 36: 238, 1972
5. Omura T, Sato R: The carbon monoxidepigment of liver microsomes. J Biol Chem 239 : 2370, 1964
6. Phillips AH, Lungdon RG: Hepatic triphos-phopyridine nucleotide-cytochrome c reductase, isolation, characterization and kinetic studies. J Biol Chem 237: 2652, 1962
7. Kutt H, Haynes J, Verebely K, et al. : The effect of phénobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes. Neurology 19: 611, 1969
8. Feely JF, Wilkinson GR, Mcallister CB, et al. : Increased toxiciy and reduced clearance of lidocaine by cimetidine. Ann Intern Med 96 : 592, 1982
9. Tucker GT, Bax ND, Lennard MS, et al.: Effects of /î-adrenoreceptor antagonists on the pharmacokinetics of lignocaine. Br J Clin Pharmacol 17: 21, 1984
10. Keenaghan JB, Boyes RN : The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J Pharmacol Exp Ther 180: 454, 1972
11. Hermansson J, Glaumann H, Karlen B, et al. : Metabolism of lidocaine in human liver in vitro. Acta Pharmacol et Toxicol 47: 49, 1980
12. Kawai R, Fujita S, Suzuki T : Simultaneous quantitation of lidocaine and its four metabolites by high-perfomance liquid chromatography : Application to studies on in vitro and in vivo metabolism of lidocaine in rats. J Pharm Sei 74 : 1219, 1985
13. Schenkmen JB: Studies on the nature of the type I and type II spectral changes in liver microsomes. Biochemistry 9 : 2081, 1970
14. Schenkman JB, Cinti DL, Orrenius S, et al. : The nature of the type I (modified type II) spectral change in liver microsomes. Biochemistry 11: 4243, 1972
15. Yoshida Y, Kumaoka H : Studies on the substrate-induced spectral change of cytochrome P-450 in liver microsomes. J Biochem 78: 455, 1975
16. Takahashi S, Shigematsu A, Furukawa T: Interaction of volantile anesthetics with rat hepatic microsomal cytochrome P-450. Anesthesiology 41: 375, 1974
17. Reilly CS, Wood AJ, Koshakji RP, et al. : The effect of halothane on drug disposition : Contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow. Anesthesiology 63: 70, 1985
18. Stenson RE, Constantino RT, Harrison DC: Interrelationships hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 43: 205, 1971